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Eukaryotic cells utilise the dynamic addition and
AU:1
AU:2
removal of SUMO, a small ubiquitin-like modifier
(UBL), to modulate protein functions, interactions
and localisation. Protein SUMOylation involves a
cascade of dedicated enzymes that facilitate the
covalent modification of specific lysine residues
on target proteins with monomers or polymers
of SUMO. The cellular homeostasis of SUMOylated
proteins is also regulated by SUMO proteases
and SUMO-targeted ubiquitin ligase (STUbLs).
SUMO proteases cleave SUMO from modified
proteins. In contrast, STUbLs ubiquitinate pro-
teins modified with SUMO chains. Recent data
suggests that ubiquitination via STUbLs effects
the turnover of SUMOylated proteins as well as
the spatio-temporal composition of complexes
that contain SUMO-modified proteins. Defects in
the controlled addition, removal and turnover of
SUMO-modified proteins greatly affect cellular
fitness and contribute to developmental defects,
cancer and protein aggregation disorders.
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Introduction
The functional spectrum of any organism’s proteome is vastly
increased by post-translational modification of individual gene
products. A single protein may be subject to modification with
small functional groups (e.g. phosphate, acetate, methyl), large
molecules (e.g. sugars and lipids) or entire proteins (e.g. ubiq-
uitin, SUMO (small ubiquitin-like modifier), and Nedd8). The
first post-translation modifier protein, ubiquitin, was discovered
in 1975 as a lymphocyte differentiation factor, and by the 1980s
it was established that ubiquitin can be covalently linked to other
proteins in an adenosine triphosphate (ATP)-dependent manner
and plays an important role in protein turnover and many other
cellular processes (Varshavsky, 2006). It took another 15 years
before a SUMO was identified. SUMO was initially cloned as
a suppressor of a Mif2 centromere mutant (Smt3) in yeast and
showed considerable homology (18%) to ubiquitin. By 1996, sev-
eral groups had identified proteins that either interacted or were
covalently modified with mammalian SUMO (reviewed in Wil-
son, 2009).
Components of the protein cascade involved in ubiquitylation
had been worked out before SUMO was discovered. After pro-
cessing, the di-glycine carboxy terminal end of ubiquitin forms
a covalent thioester bond intermediate with an ubiquitin-E1 acti-
vating enzyme in an ATP-dependent reaction. Next, ubiquitin is
transferred to one of several E2 conjugating enzymes and then
to a protein target, either directly from the E2 or in a process
facilitated by E3 ligases (for review of relevant references, see
Kerscher et al. (2006). Modification of proteins with SUMO and
its variants was found to follow an analogous process, albeit with
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SUMO-specific E1, E2 and E3 enzymes and SUMO-specific pro-
teases (see details below).
What is the role that SUMO plays in the cell? Exhaustive
mass spectrometric analyses have revealed that hundreds (if not
thousands) of proteins are SUMOylated, and at this point it is dif-
ficult to name a cellular pathway that is not somehow affected by
SUMOylation. Nevertheless, deducing the role SUMOmodifica-
tion imparts on a particular protein remains surprisingly difficult.
To date, SUMOmodification and de-modification of cellular pro-
teins have been shown to play a regulatory role in processes
including nuclear transport, signal transduction, stress response
and cell-cycle progression, just to name a few (reviewed in Var-
shavsky, 2006; Wilson, 2009; Kerscher et al., 2006; Jentsch and
Psakhye, 2013; Hickey et al., 2012). SUMO also plays a role
in protein homeostasis but, unlike poly-ubiquitinated proteins,
poly-SUMOylated proteins are not directly targeted to the pro-
teasome for degradation. Therefore, one of the most exciting
findings of late is that a specific class of SUMO-targeted ubiq-
uitin ligases (STUbLs) ubiquitinate SUMOylated proteins to be
degraded or disassembled, providing a new paradigm for the ver-
satility of the SUMO and ubiquitin modification system and the
cross-talk between different protein modifiers (Sriramachandran
and Dohmen, 2014). Several recent examples of how SUMO and
STUbLs regulate SUMO homeostasis, protein quality control,
protein aggregation and DNA (deoxyribonucleic acid) damage
repair are explained in detail below.
SUMO Variants
Mammalian cells encode three highly conserved paralogs of
AU:3
SUMO (SUMO1, SUMO2 and SUMO3), while yeast and sev-
eral other small eukaryotes only encode one. A fourthmammalian
paralogue, SUMO4, is encoded in the human genome but its role
remains enigmatic. SUMO2 and SUMO3 can form polymeric
chains and are so similar (95%) that they are often detected by the
same antibody and hence reported as SUMO2/3. SUMO1, in con-
trast, shares only about 50% identity with the other SUMO iso-
forms, lacks internal lysines for conjugation and forms polymeric
chains inefficiently. Therefore, SUMO1 mono-SUMOylates and
its substrates may also act as a chain terminator for polymeric
chains of SUMO2/3. Budding yeast SUMO, Smt3, is most simi-
lar to SUMO1 (50%) but carries internal lysines, which allow it to
form chains. Smt3 and its conjugates are enriched in the nucleus
and, outside of the nucleus, on septin proteins that form a ring at
the bud neck of dividing cells (Elmore et al., 2011 and references
therein). The sub-cellular localisation of vertebrate SUMO1 and
SUMO2/3 differs because of the protein targets to which they are
conjugated and is to some extent cell-type-specific. For example,
SUMO1 resides in in the nucleus, in distinct nuclear foci, and
is enriched at the nuclear pore complex because it modifies the
nuclear transport factor RanGAP1. SUMOylation of RanGAP1
promotes its association with the nuclear pore complex protein
RanBP2 to form a multi-subunit SUMO E3 ligase (Werner et al.,
2012). In contrast, SUMO2/3 are also enriched in the nucleus
and nuclear bodies but also associate with mitotic chromosomes
because theymodify topisomerase-2 and other chromosomal pro-
teins. Unless otherwise specified, gene and protein names in the
following discussion refer to those of budding yeast Saccha-
romyces cerevisiae.
The SUMOylation Machinery
The mechanism of SUMOylation parallels the process of ubiqui-
tination but employs a cascade of SUMO-specific enzymes that
ultimately facilitate the conjugation of SUMO to its protein target
through an isopeptide bond (Figure 1b). The E1 and E2 enzymes
of this SUMO modification cascade were identified because they
both bound to a yeast SUMO affinity column. The E1 enzyme
consists of Uba2 and Aos1, two proteins that are similar to each
other and also to Uba1, the monomeric ubiquitin E1 enzyme
(Johnson et al., 1997). Subsequently, the SUMO E2 conjugating
enzyme Ubc9 was identified because it bound a column con-
taining the SUMO/Aos1/Uba2 complex (Johnson et al., 1997).
Purified Ubc9 is able to form a thioester bond with SUMO but
not ubiquitin, and combiningUbc9, SUMO,ATP and cell extracts
resulted in the formation of high molecular weight SUMO conju-
gates. Mammalian paralogues of SUMO E1 and E2 enzymes are
called Sae1/Sae2 and Ubc9, respectively, and are involved in the
conjugation of all three SUMO isoforms described above.
Protein SUMOylation
and Consensus Sites
Proteins are SUMOylated in an ATP-dependent process that
involves the formation of a thioester bond between Uba2 and
conjugation-competent SUMO (reviewed in Kerscher et al.,
2006 and see Figure 1). Subsequently, Ubc9 binds to Aos1/Uba2
and the thioester bond is transferred to Ubc9. In the final step,
SUMO-charged Ubc9 binds a canonical SUMOylation consen-
sus motif and catalyses the formation of an isopeptide bond
between SUMO and the substrate protein (Figure 1b). The
SUMOylation consensus motifs can be represented as ψKxE/D,
with ψ being a large hydrophobic amino acid and x any residue.
SUMOylation consensus motifs are present in many proteins and
conveniently identified using programs such as SUMOplot and
others (http://sumosp.biocuckoo.org, http://www.abgent.com/
sumoplot). However, predicted SUMOylation sites must be
confirmed experimentally, which is often a difficult undertaking
because of the SUMOylation of non-consensus lysines and the
often transient (or limited) modification with SUMO. In the
end, only about half of all SUMOylated proteins expressed in
the cell contain a recognisable SUMOylation motif and require
alternative means for efficient modification (Wilson, 2009).
SUMO E3 Ligases
SUMOylation via Aos1/Uba2 and Ubc9 alone is inefficient
and, to enhance SUMOylation, all eukaryotic cells utilise
SUMO-specific E3 enzymes. SUMO E3 ligases either stimulate
Ubc9-mediated SUMOylation or facilitate the interaction of
Ubc9 with its substrates including those that lack SUMOylation
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consensus sites. Most SUMO E3 ligases are conserved members
of the Siz/PIAS-type family (protein inhibitor of activated STAT)AU:4
and interact with Ubc9 by means of a hallmark Siz1/PIAS
RING domain (SP-RING). Yeast cells lacking Siz1 and Siz2
are greatly reduced in SUMOylated proteins, underlining the
importance of SUMO E3 ligases for overall SUMOylation.
There is strong evidence that Siz/PIAS-type SUMO E3 ligases
play important roles in cellular processes, which ensure proper
chromosome segregation and genome maintenance (Nie and
Boddy, 2015 and references therein). Two additional SUMO
ligases in yeast, Mms21 and ZIP3, also contain SP-RINGs but
lack conserved domains for DNA-binding (SAP) and nuclearAU:5
retention (PINIT) that are present in the other Siz/PIAS-typeAU:6
enzymes (reviewed by Jentsch and Psakhye, 2013). Mms21 and
ZIP3 are required for recombinational DNA repair and synapse
formation, respectively.
SUMO E3 Ligases have Unique
and Overlapping Substrates
Inside the nucleus, Siz1 and Siz2 cooperate in pathways that
suppress excessive homologous recombination and prevent gross
chromosomal rearrangements. Specifically, Siz1 and Siz2 can
both SUMOylate the DNA polymerase processivity factor PCNAAU:7
to recruit the helicase Srs2 and restrict inappropriate recom-
bination (Burkovics et al., 2013 and references therein). Fur-
thermore, Siz1 and Siz2 also regulate chromosome segregation
via SUMOylation of the kinetochore protein Ndc10 and tran-
scriptional regulation via modification of histone H2B and H4
(Montpetit et al., 2006; Nathan et al., 2006). However, there are
also several examples which reveal that the functions of Siz1
and Siz2 are not entirely redundant. For example, Siz1 is the
only SUMO E3 ligase that is transported out of the nucleus to
SUMOylate septins, which form a ring-shaped scaffold at the bud
neck of dividing cells (Westerbeck et al., 2013 and references
therein). SUMOylated septins are believed to recruit important
cell-cycle regulatory proteins to the bud neck and also play a
role in septin ring disassembly. One of the functions uniquely
attributed to Siz2 is the anchoring of telomeres to the nuclear
envelope (NE). Only deletion of Siz2, but not Siz1 or Mms21,
resulted in the loss of telomeres from the nuclear periphery (see
references in Further Readings section). Several proteomics stud-
ies using mass spectrometry have helped to clarify the unique
and overlapping targets of the various SUMO E3 ligases in yeast
(Albuquerque et al., 2013; Srikumar et al., 2013). Probably the
most recent addition among the SUMO ligases is Wss1. Wss1
belongs to a new family of metalloproteases that also possess
SUMO ligase activity and is involved in resolving DNA repair
complexes. A recent study by Balakirev et al. (2015) shows that
the SUMO ligase activity of Wss1 enhances SUMO chains on
protein complexes associated with DNA breaks and this acti-
vates the protease activity of Wss1. Since Wss1 also associates
with Cdc48, a protein complex disassemblase that also interacts
with STUbLs, it is ideally suited to extract SUMOylated proteins
from chromatin, especially when DNA–protein cross-links are
present.
There are a handful of mammalian SUMO E3 ligases with
SP-RINGs, including PIAS1, PIAS3, PIASx and its splice
variants alpha and beta, PIASy and the Mms21 homologue
Nse2. In addition, mammalian cells express SUMO ligases
such as RanBP2, an NPC-associated protein involved in nucleo-
cytoplasmic trafficking and chromosome segregation, and sev-
eral CBX proteins that are related to the polycomb protein Pc
in Drosophila melanogaster and play a role in transcriptional
repression (reviewed in Wang and Dasso, 2009). Both RanBP2
and CBX proteins do not contain an SP-RING and use mech-
anisms distinct from PIAS-type enzymes for SUMO ligation.
Proteins of the SprT family that are similar to yeast Wss1 play
a role in protecting stalled replication forks in mammalian cells.
However, as yet there is no evidence that they possess the ability
to form SUMO chains or exhibit protease activity (Balakirev
et al., 2015).
As the name indicates, PIAS proteins were originally iden-
tified due to their ability to bind and modulate the activity of
STAT transcription factors. Indeed, PIAS proteins bind and even
SUMOylate STATs but this modification may not play a role in
transcriptional repression. On the other hand, PIAS1 and PIAS4
are critically important for double-strand breaks (DSB)-repair
signalling involving SUMO and ubiquitin at sites of DSB repair
(Galanty et al., 2009). Briefly, SUMOylation by PIAS1 and
PIAS4 leads to recruitment of the STUbL RNF4 (discussed
below) and promotes DSB repair by remodelling complexes
that accumulate at DSB repairs (Galanty et al., 2012). Another
recent example underscores the function of PIAS proteins in
cancer-related signalling pathways and involves PIASxα. PTEN,
a tumor suppressor and negative regulator of the PI3K-Akt sig-
nalling pathway, was shown to be SUMOylated by PIASxα; when
two SUMO-acceptor lysines on PTEN were mutated, the protein
was ubiquitinated and degraded. Correlatively, overexpression of
PIASxα in nude mice reduced tumor size, but only when PTEN
was also expressed. These findings suggest that SUMOE3 ligases
may be considered tumor suppressors (Wang et al., 2014).
Dual SUMO and Ubiquitin Ligase
Interestingly, some mammalian E3 ligases are reported to have
dual SUMO and ubiquitin ligase activities. These include topoi-
somerase I binding, arginine/serine-rich E3 ligases (TOPORS)
that SUMOylate p53, TNF receptor-associated factor 7 (TRAF7)
involved in SUMOylation of c-Myb, the tripartite motif contain-
ing 27 (TRIM27) that SUMOylates Mdm2 and the ubiquitin E3
ligase UHRF2 that SUMOylates ZNF131 (Oh and Chung, 2013).
It is telling that mutating the RING domain in these proteins
ablates either the SUMO ligase activity (TRIM27) or the ubiq-
uitin ligase activity (TOPORS), but not both. Therefore, it is
apparent that distinct mechanisms for SUMO and ubiquitin liga-
tion are at work.
DeSUMOylation
Protein SUMOylation is reversible, and SUMO conjugates can be
cleaved by SUMO-specific proteases. The first SUMO-specific
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protease, Ulp1p, was identified in a biochemical screen for
Smt3/SUMO-cleaving enzymes among yeast proteins expressed
in Escherichia coli (Hochstrasser and Li, 1999). Subsequently,
a second SUMO protease, Ulp2p/Smt4p, was identified as a
SUMO-cleaving enzyme because of its homology to Ulp1p’s
cysteine protease (Li and Hochstrasser, 2000). The two yeast
SUMO proteases, Ulp1 and Ulp2, contain a conserved cys-
teine protease domain that can remove the SUMO moiety from
modified proteins.
Specifically, Ulp2 plays a role in the removal of SUMO
and SUMO chains from nuclear proteins. Ulp1, as mentioned
above, has two contrasting cellular functions. Ulp1 first facil-
itates SUMOylation by processing precursor SUMO into its
conjugation-competent form. Additionally, Ulp1 also facilitates
deSUMOylation by removing SUMO from nuclear and cytoso-
lic proteins after conjugation. Therefore, impairment of Ulp1
results both in the accumulation of SUMO conjugates and the
inability to carry out de novo SUMOylation. The resulting lack
of mature SUMO has been shown to adversely affect cellu-
lar DNA repair processes, the processing and export of the
60S pre-ribosomal particle, nucleus–cytoplasm trafficking and
cell viability (reviewed in Hickey et al., 2012). The best evi-
dence that Ulp1 plays a unique role in cell cycle progres-
sion comes from a temperature-sensitive ulp1 mutant (ulp1ts),
which arrests in the G2/M phase of the cell cycle. This mutant
accumulates cell-cycle-stage-specific SUMO conjugates at per-
missive and non-permissive temperatures. However, expression
of mature SUMO in the ulp1ts mutant neither suppresses the
temperature-sensitive phenotype nor the lethality of a ULP1 dele-
tion (Hochstrasser and Li, 1999). This finding suggests that the
lethality of Ulp1 mutants may be due to the failure to remove
SUMO from important cell-cycle regulators. The proteins that
Ulp1 must deSUMOylate to ensure proper cell cycle progression
have not yet been identified, but a recent study in fission yeast
suggests that the SUMO E3 ligase Siz1/Pli1 may be one of them
(Nie et al., 2012a).
The SUMO proteases Ulp1 and Ulp2 are exquisitely conserved
and have been found in yeasts, flies, fish, mice and humans. The
catalytic domain of Ulp1 is most similar to mammalian SENP1
and SENP2, while Ulp2 is more similar to SENP6 and SENP7.
SENP proteins differ in intracellular localisation, SUMO iso-
type preference, ability to process SUMO precursors and sub-
strate specificity. Functionally, the different SENPs are involved
in various processes such as ribosome biogenesis (SENP3 and
SENP5), kinetochore assembly (SENP6), transcriptional regula-
tion (SENP1 and SENP2), cell division and mitochondrial inher-
itance (SENP5), just to name a few (Hickey et al., 2012; Wang
andDasso, 2009). Clinically, SUMOhomeostasis has been linked
to cancer progression (prostate, liver, colon and adenocarcinoma)
and in at least a few of these cases the alteration in SUMO home-
ostasis has been linked to the dysregulation of the SUMO pro-
tease SENP1 (Zhang et al., 2013; Wang et al., 2013). It remains
unknown how many SENP proteins are involved in disease pro-
gression and exactly which SUMOylated substrates are involved.
It is, however, clear that SUMO and SUMO pathway proteins
have taken a place as important biomarkers in research and dis-
ease diagnosis.
How do SUMO Proteases Target
their SUMOylated Substrates?
The substrate specificity of SUMO proteases is, at least in part,
regulated through their localisation. For example, yeast Ulp2
and vertebrate SENP6 and SENP7 SUMO proteases localise
within the nucleus. In contrast, both Ulp1 and vertebrate SENP1
and SENP2 are enriched at the NE through their interactions
with the nuclear pore complex (Elmore et al., 2011 and refer-
ences therein). The sub-cellular localisation of SUMO proteases
appears to be regulated by their amino-terminal extensions, lim-
iting potential substrates that are accessible to SUMO proteases.
Unfortunately, there is still limited information about how SUMO
proteases target their respective nuclear and cytosolic substrates
in vivo (Elmore et al., 2011). One possibility is that SUMO pro-
teases may contain structural features that allow for non-covalent
interactions with SUMO and SUMO-modified proteins as they
enter the nucleus. Indeed, conserved SUMO-interacting motifs
(SIMs) (detailed below), have been predicted in the non-catalytic
domains of yeast SUMO protease Ulp2, as well as mammalian
SENP1,2,6,7 and DESI, a recently discovered new SUMO pro-
tease (reviewed in Hickey et al., 2012; Jentsch and Psakhye,
2013). However, the functional relevance of these predicted SIMs
is unclear. For example, mutating SIMs in the carboxy-terminal
domain of Ulp2 caused only a mild accumulation of poly-SUMO
chains, while the ability to bind SUMO chains in vitro was
not affected (Hickey et al., 2012 and references therein). SIMs
have also not been experimentally confirmed in Ulp1; rather, the
crystal structure of the catalytic domain bound to yeast SUMO
reveals that both proteins interact through multiple residues that
are distributed across a SUMO-binding surface and form salt
bridges with SUMO (Mossessova and Lima, 2000). Only the car-
boxy terminus of bound SUMO is inserted into a hydrophobic
tunnel that leads towards Ulp1’s active site. SUMO process-
ing and de-conjugation require an active-site cysteine residue
that resides at the end of this tunnel. It has been suggested that
this configuration is conserved in the SENPs and may allow for
the accommodation of many different SUMOylated proteins, as
well as unprocessed SUMO precursors (Mossessova and Lima,
2000). If the catalytic cysteine of some SUMO proteases, for
example, Ulp1 and SENP1, is replaced with a non-catalytic ser-
ine or alanine, these proteins trap their SUMOylated substrates. A
substrate-trapping Ulp1 mutant has been exploited to study how
this SUMO protease is targeted to septins and other SUMOylated
targets in vivo and in vitro (Elmore et al., 2011).
SUMO as a Building Block
for Macromolecular Assemblies
Our understanding of SUMO biology and function has been
significantly advanced by the discovery of proteins and protein
domains that contain SIMs, which interact non-covalently with
SUMO. A canonical SIM sequence consists of a hydrophobic
core (e.g. V/I-X-V/I-V/I) that is often juxtaposed with a stretch
of acidic and/or phosphorylated amino acids (Kerscher et al.,
2006). Only one type of SIM has been identified for SUMO with
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additional reports of specific zinc finger proteins being able to
bind SUMO (Guzzo et al., 2014). In contrast, there are close
to 20 structurally diverse families of ubiquitin-binding domains
(UBDs) for ubiquitin (Rahighi and Dikic, 2012). Additional
SUMO-binding and SIM-like domains are predicted to exist
but have yet to be found or confirmed. Proteins that otherwise
lack sufficient affinity for each other may interact via SUMO
and SIMs. This can be useful for subcellular targeting and
the formation of large protein complexes, for example, during
the biogenesis of nuclear bodies (e.g. PML bodies) (Kerscher,
2007). Additionally, some proteins contain both SIMs and
ubiquitin-interacting motifs, and it is believed that these proteins
may be able to interact with hybrid SUMO–ubiquitin chains
formed by STUbLs. For example, hybrid SUMO–ubiquitin
chains formed by the STUbLs Slx5/Slx8 and RNF4 are recog-
nised by yeast Ufd1 (the substrate-recruiting cofactor of the
Cdc48p-Npl4p-Ufd1p complex) and mammalian Rap80 (a
ubiquitin-interacting motif containing protein with a role
in the DNA damage response), respectively. These hybrid
SUMO–ubiquitin chains represent SUMO-dependent signals
that have been shown to orchestrate DNA repair functions
(Guzzo and Matunis, 2013; Nie et al., 2012b).
STUbLs
STUbLs, the first functionally identified in yeasts, have given
credence to a proteolytic role of SUMO. STUbLs are ubiquitin
E3 ligases that can specifically target and bind SUMO chains or
proteins modified with SUMO chains and facilitate their ubiq-
uitination (Figures 2 and 3). Members of this unusual family
of ubiquitin ligases are well conserved, contain a RING domain
required for their ubiquitylation activity and use multiple SIMs to
target SUMOylated substrates. There are at least four STUbL pro-
teins in the budding yeast S. cerevisiae (Slx5, Slx8, Uls1/Ris1 and
Rad18), three in fission yeast S. pombe (Rfp1, Rfp2, and Slx8)
and at least two in multicellular eukaryotes including humans
(RNF4 and Arcadia/RNF111) (Sriramachandran and Dohmen,
2014). Budding yeast Slx5 and Slx8 form a STUbL complex,
which plays an important role in the DNA damage response,
genome maintenance and the proteasome-mediated degradation
of specific transcriptional regulators. Included in a growing list
of experimentally confirmed ubiquitylation targets of Slx5/Slx8
are the transcriptional regulators Mot1 and Matalpha2 (in vivo),
the homologous recombination protein Rad52 (in vitro) and
SUMOylated Siz1 (in vitro and in vivo). In contrast, Uls1/Ris1
plays a role in counteracting replicative stress and telomere main-
tenance. Two interesting targets of the Uls1 STUbL are SUMOy-
lated Rap1, a transcriptional regulator that has been implicated
in preventing telomere fusions, and the cytosolic nuclear migra-
tion protein Pac1 that targets dynein to the ends of microtubules.
Rad18, a ubiquitin ligase that is stimulated by SUMOylation of
its substrate, the sliding clamp protein PCNA, is likely the newest
member of a growing family of STUbLs in yeast and beyond
(STUbLs and STUbL substrates are excellently reviewed in Sri-
ramachandran and Dohmen, 2014).
STUbL-mediated ubiquitylation does not always result in the
immediate proteasome-mediated degradation of SUMOylated
target proteins. For example, there is now good evidence that
Cdc48-Ufd1-Npl4, an ATPase complex that dislodges proteins
from chromatin, is targeted to SUMO and ubiquitin co-modified
substrates to protect cells from genome instability (Nie et al.,
2012b; Bergink et al., 2013). It is, therefore, likely that STUbLs
and Cdc48-Ufd1-Npl4 cooperate to disrupt DNA-associated pro-
tein complexes and target them for subsequent degradation. Taken
together with the observation that the Wss1 SUMO-activated
protease also interacts with Cdc48, a theme emerges as to how
SUMOylation can lead to the remodelling and disassembly of
protein complexes.
Regulation of SUMO Pathway
Components by STUbLs
SUMOylation is a highly dynamic process, and SUMOylation
patterns in the cell change rapidly in response to cell-cycle
stage or cell stress. Several interesting studies have emerged that
detail how SUMO pathway components are regulated to control
SUMO homeostasis in the cell. First, oxidative stress rapidly (and
reversibly) disables SUMO E1 (Uba2) and E2 (Ubc9) enzymes
via the formation of a disulfide bond between their catalytic cys-
teines (Bossis and Melchior, 2006). Second, in yeast, increased
auto-SUMOylation of the SUMO conjugating enzyme Ubc9 was
found to reduce its ability to SUMOylate septins in mitosis (Ho
et al., 2011). Third, several human SENPs (1,2,3,6,7) are rapidly
disabled by heat stress, thus allowing for the rapid accumulation
of SUMO conjugates and SUMO chains when cells are subjected
to heat stress (Pinto et al., 2012).
More recently, two studies provide a glimpse into the role
that auto-SUMOylation plays in the regulation of SUMO E3
ligases. Westerbeck et al. (2013) identified Siz1 as an interactor
with the STUbL subunit Slx5 and found that deletion of Slx5
increases the steady-state level of SUMOylated Siz1. Normally,
Siz1 is exported from the nucleus via the karyopherin Msn5 to
SUMOylate bud-neck-localised septins. However, the authors of
this study found that, if its nuclear export in mitosis is prevented
by deletion of Msn5, auto-SUMOylated Siz1 accumulates and is
rapidly degraded by the Slx5/Slx8 STUbL (Figure 4). A similar
observation was made by Nie et al. (2012a) who found that levels
of the SUMOylated Siz1 orthologue Pli1 in fission yeast is rapidly
degraded in a nup132Δ mutant leading to its STUbL-dependent
degradation. The authors found that SUMOylated Pli1 in the
nup132Δ cells increased because the levels and activity of the
SUMO protease Ulp1 were reduced in this mutant. In summary,
both findings suggest that STUbLs play an important role in
the cell-cycle-specific degradation of the SUMOylated Siz1/Pli
E3 ligase and this raises the possibility that other SUMO-E3
ligases (e.g. Siz2 and Mms21, PIAS) and SUMOylated Ubc9 are
regulated in a similar manner.
STUbLs have their RING Fingers
in DNA Repair
STUbLs, reviewed above, are also intricately involved in
DSB-repair-related processes. For example, yeast cells harboring
eLS © 2015, John Wiley & Sons, Ltd. www.els.net 5
els a0026004.tex V2 - 12/22/2015 6:17 P.M. Page 6
SUMOylation
Version 2 a0026004
a deletion of SLX5 or SLX8 are hyper-sensitive to genotoxic
insults. Furthermore, cells lacking these STUbLs accumulate
gross chromosomal rearrangements, show enhanced foci of the
DNA repair protein Rad52, associate with dsDNA breaks and
ubiquitinate Rad52 in vitro. Attesting to the high degree of
structural and functional conservation of STUbLs, RNF4 can
suppress a variety of DNA damage phenotypes associated with
deletions of SLX8 and SLX5, or both (Mullen et al., 2011). One
important aspect of the initial characterisation of human RNF4
focused on its interaction with PML, a tumour suppressor and
main constituent of PML nuclear bodies that plays a critical
role in the response to genotoxic insults (reviewed in Reineke
and Kao, 2009). RNF4 can be recruited to PML bodies and this
recruitment is enhanced by SUMO, leading under some condi-
tions to the degradation of the PML protein. As detailed below,
our functional understanding of the relevance of the interaction
between PML and RNF4 is still far from complete.
Recently, several studies have focused on the question of how
RNF4 plays into the choreography of DSB repair. These studies
show that RNF4 is involved in recruiting and remodelling pro-
teins at sites of dsDNA breaks (Luo et al., 2012; Galanty et al.,
2012; Yin et al., 2012). Using laser micro-irradiation assays,
it was shown that RNF4 visibly accumulates at dsDNA breaks
within 15 min of DNA damage and that its SIMs are involved
in this localisation (Yin et al., 2012; Luo et al., 2012). RNF4
appears to be recruited to the dsDNA break site because of
SUMOylated Mdc1. Mdc1, a DNA damage checkpoint medi-
ator protein, is recruited early to the dsDNA break site and is
then SUMOylated by PIAS1/4. The authors of two studies also
show that recruitment of 53BP1, a DNA damage response factor
that recognises altered chromatin at dsDNA breaks, is dependent
on RNF4. As the dsDNA break repair response unfolds, Mdc1
and 53BP1 disappear as Rad51 accumulates on single-stranded
resected DNA. This exchange for Rad51 requires the removal of
RPA1 that coats single-stranded DNA at resected DNA breaks.
However, this exchange does not take place when RNF4 is
depleted or the SUMO-dependent interaction with Mdc1 (and
RPA1) is prevented. One simplified model is, then, that these
early responders (especially SUMOylatedMdc1 and RPA1) must
be removed from dsDNA breaks via RNF4-mediated ubiquitina-
tion so that Rad51-mediated homologous recombination can take
place. Finally, RNF4 is also involved in recruiting the 19S protea-
some regulator subunit PSMD4 to dsDNA breaks, linking RNF4s
function in remodelling the dsDNA break site to protein turnover
(Luo et al., 2012). The model painted by these studies is by no
means complete, and there remains the pressing question of why
several additional ubiquitin ligases, such as RNF8, RNF168 and
BRCA1, can also be found at dsDNA break sites and whether
they cooperate with RNF4. One possible answer may be found in
the observation that ligases can produce distinct kinds of ubiqui-
tin chains. For example, RNF4 produces hybrid SUMO–ubiquitin
chains (K-63-linked ubiquitin chains on SUMO) that are recog-
nised by the adapter protein Rap80 and help to recruit BRCA1,
which is known to form ubiquitin chains linked via lysine 6 on
ubiquitin (Guzzo et al., 2012). The various SUMO and ubiquitin
chains therefore have the potential to signal the processing stage
of dsDNA breaks, ensuring that the appropriate DNA repair fac-
tors are recruited, assembled, removed or degraded at the appro-
priate time (Figure 5). See also:DNA Strand Break Repair and a0021478
Human Genetic Disease
RNF4 Takes on Cystic Fibrosis
The observation that Slx5/Slx5 plays a role in the proteolytic
turnover of a mutant transcriptional regulator in yeast, Mot1-103,
provided the first indication that STUbLs are involved in pro-
tein quality control (Wang and Prelich, 2009). Recent work by
Ahner et al. (2013) extends on this finding by showing that a
mutant form of the cystic fibrosis transmembrane conductance
regulator (CFTR), the protein responsible for the debilitating res-
piratory disease cystic fibrosis, is regulated by SUMO and RNF4.
One mutation in CFTR that results in cystic fibrosis is due to
the loss of a phenylalanine residue at position 508 of the CFTR
protein (CFTRΔF508), which prevents the protein from leaving
the endoplasmic reticulum (ER) to assume its normal function in
transporting chloride ions across the plasma membrane. Ahner
et al. determined that overexpression of a small heat shock pro-
tein, Hsp27, resulted in the increased degradation of CFTRΔF508
but not wild-type CFTR in a cell culture model. Since Hsp27
is predicted to interact with Ubc9, the authors investigated
whether SUMOylationwas involved inHsp27-mediated degrada-
tion of CTFR. Indeed, overexpression of Ubc9 resulted in reduced
steady-state levels of CFTRΔF508 while having no effect on
wild-type CTFR. Correspondingly, overexpression of Senp1 (a
SUMO protease) increased the levels of both CFTRΔF508 and
wild-type CTFR. In vitro, CFTRΔF508, but not wild-type CTFR,
was SUMOylated by Ubc9. This increased SUMOylation was
correlated to the association of Hsp27 with CFTRΔF508, result-
ing in the increased recruitment of Ubc9. In addition, the authors
propose that the misfolding caused by the mutation exposes addi-
tional SUMOylation sites, an interesting hypothesis that remains
to be tested.
Although the effect of SUMOylation on the CFTRΔF508
mutant is interesting in itself, it did not explain the degradation
of CTFR. Therefore, the authors examined RNF4 as a poten-
tial ubiquitin ligase for SUMOylated CTFR. Overexpression of
RNF4, but not a dominant-negative RNF4 RING mutant, prefer-
entially reduced CFTRΔF508 levels.
In summary, this work provides important evidence for the
critical role of SUMO and RNF4 in protein quality control
functions. In this particular case, RNF4 engages a non-nuclear
substrate that is also well-studied in endoplasmic reticulum asso-
ciated degradation (ERAD). There is currently no evidence that
RNF4 leaves the nucleus to interact with its substrates. However,
a previous study revealed that an ER membrane-embedded ubiq-
uitin ligase (Doa10) gains access to the inner nuclear membrane
to interact with a nuclear substrate (Deng and Hochstrasser,
2006). Therefore, it will be interesting to determine whether the
RNF4-mediated ubiquitylation of CFTRΔF508 takes place in the
cytosolic compartment as proposed, or at the inner nuclear mem-
brane that is contiguous with the ER. See also: Degradation of a0022577
Misfolded Secretory and Membrane Proteins and Associated
Diseases
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Spinocerebellar ataxia type 1 (SCA1) is an untreatable neu-
rodegenerative disorder resulting a progressive loss of physi-
cal control over muscle movements and speech of the patients
afflicted. The causative agent behind SCA1 is the expression of
a polyglutamine-expanded variant of the Ataxin protein (Atxn1).
Atxn1 with less than 35 glutamine residues is considered nor-
mal, while variants of Atxn1 with more than 39 are increasingly
pathogenic (Pagon et al., 1993). Both normal and pathogenic
Atxn1 are enriched in the nucleus and co-localise, at least in part,
with PML nuclear bodies. However, expression of the pathogenic
Atxn1 (e.g. Atxn1 80Q) is believed to interfere with critical
nuclear functions, especially transcription, and results in nuclear
Atxn1 inclusions that affect the size, distribution and contents of
PML nuclear bodies.
Both normal and pathogenic Atxn1 are SUMOylated, and
it was found that an increase in poly-Q length negatively
affected the levels of SUMO1-modified Atxn1 (Riley et al.,
2005). More recently, Guo et al. (2014) functionally con-
nected these observations. They found that co-overexpression
of PML and Atxn1 dramatically reduced the levels of
polyglutamine-expanded, aggregated Atxn1 80Q but not soluble
Atxn1 80Q or normal Atxn1 30Q, suggesting that PML specifi-
cally targets the pathogenic variant for degradation. The authors
tested several conditions and found that the effect of PML was
negated when proteasome function was inhibited, when SUMO2
was absent or unable to form chains and when a mutant of
RNF4 was expressed. In summary, the authors proposed that
PML acts as a SUMO E3 ligase that interacts specifically with
insoluble Atxn1 80Q, causing its SUMOylation and subsequent
RNF4-mediated degradation.
Indeed, has been shown previously that PML can SUMOylate
proteins in a RING-dependent manner (Quimby et al., 2006).
Even though this study primarily focused on Atxn1, it also inves-
tigated whether another poly-Q expanded protein, huntingtin Htt
97Q, the causative agent of Huntington’s disease, could be tar-
geted by PML and RNF4. Unlike Atxn1, Htt 97Q forms both
cytosolic and nuclear aggregates. Overexpression of RNF4 dra-
matically reduced the steady-state levels of insoluble huntingtin,
while PML overexpression was less effective and only affected
nuclear Htt aggregates. It is noteworthy that Htt 97Q is also
SUMOylated by other SUMO E3 ligases such as PIAS1, as was
shown by O’Rourke et al. (2013). Ultimately, it appears clear at
this point that STUbLs cooperate with several SUMO E3 lig-
ases to manage aggregation-prone proteins in eukaryotic cells.
See also: Huntington Diseasea0005150
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Key Concepts
• SUMO encodes a small ubiquitin-like modifier that is covalently
attached to lysines in target proteins.
• SUMOylation, the process of SUMO conjugation to a target
protein, frequently occurs on a lysine situated in a SUMOylation
consensus site.
• SUMO conjugates can be removed from target proteins by
SUMO-specific proteases.
• Vertebrates express three different SUMO isoforms: SUMO1,
SUMO2 and SUMO3, encoded by three different genes.
• SUMOs can form polymers via internal SUMOylation sites in
SUMO2 and SUMO3.
• Several proteins can bind non-covalently to SUMOs via SUMO
interaction motifs (SIMs).
• A finely balanced SUMOylation/de-SUMOylation system is
required for eukaryotic life.
• Cross-talk between SUMOylation and ubiquitination plays a
critical in the turnover of some SUMOylated proteins as well
as the spatiotemporal composition of complexes that contain
SUMO-modified proteins.
Glossary
Consensus SUMOylation site# A target protein site that is
frequently used for SUMO conjugation and that is defined as
ψKxE/D, where ψ represents a large hydrophobic amino acid
and x can be any amino acid.
E1# The enzyme that activates SUMO for conjugation.
E2# The enzyme that conjugates SUMO to target proteins.
E3# A SUMO ligase (e.g. Siz/PIAS) that catalyses
SUMOylation.
Ulp/SENP# A SUMO-specific protease that removes SUMO
from target proteins.
SUMO (small ubiquitin-like modifier)# Small proteins
belonging to the ubiquitin family that are covalently attached
to target proteins in the process referred to as SUMOylation.
STUbL# A SUMO-targeted ubiquitin ligase (e.g. Slx5/Slx8 or
RNF4) that uses SUMO-interacting motifs to interact with
SUMO chain-modified proteins. RING domains are a
hallmark of STUbls and are required for ubiquitylation.
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Figure 1 SUMOylation. (a) The SUMO precursor is rendered conjugation-competent by processing through a SUMO protease (Ulp/SENP). In an
ATP-dependent reaction, the conjugation-competent SUMO is transferred to an activating enzyme (E1), handed off to an conjugating enzyme (E2) and
finally transferred to the substrate in a reaction that frequently requires a SUMO ligase (E3). SUMO chains on substrates are generated by multiple E1/E2/E3
cycles and depend on internal lysines in SUMO. SUMO and SUMO chains can be pruned by SUMO proteases. SUMO chains play an important role in the
interaction with other proteins that contain SIMs to interact with SUMOylated proteins. (b) Depiction of an isopeptide bond through a lysine side chain of
the substrate and the carboxy-terminal glycine of the processed SUMO protein.
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USUMO substrate SUMOS Ubiquitin
Figure 2 Consequences of SUMOylation. SUMO E1, E2 and E3 enzymes are involved in the covalent modification of proteins with monomeric SUMO
or polymeric SUMO chains. SUMOylation can modulate the activity, localisation and interactions of a modified protein. STUbLs target and ubiquitinate
proteins modified with SUMO chains, resulting in the formation of hybrid SUMO/ubiquitin chains. These modifications can be reversed by the activity of
SUMO proteases (Ulp/SENP) or deubiquitinating enzymes (DUB). Ultimately, hybrid SUMO/ubiquitin chains lead to proteasome-mediated degradation,
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Figure 3 STUbL-mediated ubiquitylation of SUMOylated proteins. Slx5 and Slx8 are RING-domain proteins that heterodimerise to form a STUbL complex
(mammalian RNF4 forms a homodimer). Slx5 is the targeting subunit of this complex and contains at least four SIMs (\|/) that facilitate its binding to
SUMOylated substrates (red protein with a chain of green SUMO monomers). A ubiquitin E2, Ubc4 or Ubc6, is required to ubiquitylate SUMOylated
proteins in a reaction dependent on RING domains in both Slx5 and Slx8.
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Figure 4 STUbL-mediated degradation of the nuclear pool of SUMOylated Siz1. At the onset of mitosis, the SUMO ligase Siz1 becomes phophorylated (p)
via an unknown kinase and exported to the cytosol via the karyopherin Msn5. In msn5Δmutants (x), SUMOylated Siz1 acumulates in the nucleus, becomes





























Figure 5 STUBL-mediated rearrangement of a protein complex in the nucleus. (I) SUMOylated proteins can accumulate in the nucleus, possibly as part of
a protein/DNA complex. Examples described in this review include SUMOylated Siz1, Ataxin and several DNA repair proteins. (II) STUbls are recruited to
proteins modified with SUMO chains resulting in the formation of hybrid SUMO/ubiquitin chains. (III) The formation of hybrid SUMO/ubiquitin chains on
the STUbL target proteins may lead to targeting, extraction and disassembly of the associated protein/DNA complex, possibly via the disassemblase Cdc48.
The extracted ubiquitylated protein may be subject to proteasome-mediated degradation, while SUMO and ubiquitin chains are cleaved and degraded.
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